Local Serpin Treatment via Chitosan-Collagen Hydrogel after Spinal Cord Injury Reduces Tissue Damage and Improves Neurologic Function
Autor: | Enkidia A. Awo, Christian J. Kwiecien-Delaney, Jordan R. Yaron, Jacek M. Kwiecien, Michelle Burgin, Lauren N. Schutz, Wojciech Dabrowski, Alexandra Lucas, Liqiang Zhang |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
lcsh:Medicine Inflammation Pharmacology Neuroprotection Article 03 medical and health sciences 0302 clinical medicine Immune system Edema medicine Spinal cord injury chitosan-collagen hydrogel immune modulation business.industry lcsh:R serpin General Medicine medicine.disease spinal cord injury 030104 developmental biology inflammation Self-healing hydrogels Crush injury medicine.symptom business Infiltration (medical) 030217 neurology & neurosurgery |
Zdroj: | Journal of Clinical Medicine Volume 9 Issue 4 Journal of Clinical Medicine, Vol 9, Iss 1221, p 1221 (2020) |
ISSN: | 2077-0383 |
DOI: | 10.3390/jcm9041221 |
Popis: | Spinal cord injury (SCI) results in massive secondary damage characterized by a prolonged inflammation with phagocytic macrophage invasion and tissue destruction. In prior work, sustained subdural infusion of anti-inflammatory compounds reduced neurological deficits and reduced pro-inflammatory cell invasion at the site of injury leading to improved outcomes. We hypothesized that implantation of a hydrogel loaded with an immune modulating biologic drug, Serp-1, for sustained delivery after crush-induced SCI would have an effective anti-inflammatory and neuroprotective effect. Rats with dorsal column SCI crush injury, implanted with physical chitosan-collagen hydrogels (CCH) had severe granulomatous infiltration at the site of the dorsal column injury, which accumulated excess edema at 28 days post-surgery. More pronounced neuroprotective changes were observed with high dose (100 µ g/50 µ L) Serp-1 CCH implanted rats, but not with low dose (10 µ L) Serp-1 CCH. Rats treated with Serp-1 CCH implants also had improved motor function up to 20 days with recovery of neurological deficits attributed to inhibition of inflammation-associated tissue damage. In contrast, prolonged low dose Serp-1 infusion with chitosan did not improve recovery. Intralesional implantation of hydrogel for sustained delivery of the Serp-1 immune modulating biologic offers a neuroprotective treatment of acute SCI. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |